MGDII College of Health Inventors

The MGDII College of Health Inventors is a group of McMaster faculty, staff, and alumni who have shown interest and success in entrepreneurship and innovation. This group, working together, will provide McMaster with insight into issues of commercial/entrepreneurial interest. They will provide each other and associate members with advice concerning topics of mutual interest and address questions of how to raise the initial funds to move a project along, protect IP, and when to step back and have professionals develop the product etc.

Full Membership

Full members have demonstrated both interest and success in entrepreneurship, commercialization, and innovation. Metrics include the development of companies, licensing agreements and issued patents among others.

Full members include:
  • Founders of companies that have raised significant investment (i.e. series A from investors, strategic partnerships with companies; not just grants) or generating revenues
  • Lead inventors on patents that have been licensed to companies currently developing the IP

Associate Membership

Associate members have demonstrated interest in commercialization, licensing, and company development, which has not yet come to fruition. They will gain mentorship and start-up advice etc. from each other and the full members of the College of Inventors.

Associate members will include:
  • Founders of new companies seeking investment
  • Lead inventors on patents being marketed by MILO with active ongoing research program to support said inventions
  • Individuals who have filed disclosures with MILO and demonstrate an interest to commercialize

Current College of Health Inventors

Chair of Full Members

Dr. Sheila Singh, MD, PhD

Dr. Sheila Singh, MD, PhD

McMaster University, Department of Surgery, Division of Pediatric Neurosurgery
  • Co-founder and CEO, Empirica Therapeutics (focused on the development of novel rationally designed immunotherapies against glioblastoma and brain metastasis)
  • Patented a suite of novel immunotherapies against CD133 as a potential target for anti-cancer chemotherapeutics, for use in GBM, brain metastases, CML and other solid cancers; Discovered Brain Tumour Initiating Cell, a Cancer Stem Cell Founding Director, McMaster Surgeon-Scientist Program (SSP)

Deputy Chair of Full Members

Dr. Mark Larché, PhD

Dr. Mark Larché, PhD

McMaster University, Department of Medicine, Division of Clinical Immunology & Allergy
  • Co-founder of Circassia Ltd (speciality pharmaceutical company, respiratory disease) and Scientific Advisor Adiga Life Sciences (peptide immunotherapy)
  • Inventor on several patents related to use of synthetic peptides for allergen desensitization
  • Research focus on immunological tolerance for the treatment of chronic inflammatory disease

Chair of Associate Members

Dr. Jeremy Hirota

Dr. Jeremy "Jay" Hirota, PhD

McMaster University, Department of Medicine, Division of Respirology
  • Founder, Hiropharm Therapeutics (a consulting company that develops pre-clinical models of chronic respiratory diseases and mucosal immunology)
  • Founder, Infinotype (a consulting and services company that functions to bridge bioinformaticians and respiratory researchers with an in-house focus on development of diagnostic signatures
  • Canada Research Chair, Respiratory Mucosal Immunology
  • The Hirota Lab is creating a translational research program with a focus on respiratory mucosal immunology

Dr. Mehran Anvari, Phd

Dr. Mehran Anvari, MBBS, PhD

McMaster University, Department of Surgery
  • World-renowned pioneer in telerobotic and laparoscopic surgical techniques including remote surgery
  • Scientific Director and CEO, the Centre for Surgical Invention and Innovation, a Centre of Excellence in Commercialization and Research (NCE-RCE)
Dr. Mick Bhatia, PhD

Dr. Mick Bhatia, PhD

McMaster University, Department of Biochemistry and Biomedical Sciences
  • Chief Scientific Officer, Actium Inc
  • Founder and Shareholder, Kisoji Biotechnology
  • Inventor on multiple patents related to disease models, prognostics, and therapies for cancer
  • Leader in differentiation of human stem cells and its application
Dr. Jonathan Bramson, PhD

Dr. Jonathan Bramson, PhD

McMaster University, Department of Pathology & Molecular Medicine
  • Co-founder, Triumvira Immunologies, Inc. (commercializing T cell Antigen Coupler to recruit the bodies T cells and direct them to attack cancer cells)
  • Cancer immunology and T cell mobilization
Dr. Philip Britz-McKibbin, PhD

Dr. Philip Britz-McKibbin, PhD

McMaster University, Department of Chemistry & Chemical Biology
  • Research expertise in bio-analytical chemistry and metabolomics for the discovery of clinically relevant biomarkers for early detection of chronic/inherited human diseases
  • Inventor of biomarker panels for improved screening of cystic fibrosis, allosteric activators for treatment of phenylketonuria,and method for surveillance of iodine deficiency
  • A patented method for comprehensive drug screening being commercialized by a Canadian diagnostic company based on multiplexed capillary electrophoresis-mass spectrometry technology
Dr. Eric Brown, PhD

Dr. Eric Brown, PhD

McMaster University, Department of Biochemistry & Biomedical Sciences
  • Co-founder, Zumedix (company focused on antimicrobial drug development); Inventor on multiple patents related to novel antibiotics and screening methods
  • Leader in antibiotic drug resistance and infectious disease
  • Former Chair and Director, Biomedical Discovery and Commercialization Program
Dr. Anthony Chan, OOnt

Dr. Anthony Chan, MD

McMaster University, Department of Pediatrics
  • Inventor of technologies that have been licensed and developed by Canadian and international pharmaceutical companies; patent families related to medical device coating compositions and diagnostics
  • Co-invented a methodology for monitoring clotting in patient samples for studies/clinical trials
  • Provides 24/7 consultation worldwide for pediatric thrombosis and stroke through a toll-free service (1800NOCLOTS)
Dr. Teresa Chan, MD

Dr. Teresa Chan, MD

McMaster University, Department of Medicine, Emergency Medicine
  • Founding member, CanadiEM website
  • Creator, McMaster Emerg Med Games Intrapreneurship Venture (makers of GridlockED and TriagED serious educational games)
  • Founding member and Chief Strategic Officer, International Faculty Incubator program for the Academic Life in Emergency Medicine (ALiEM) group
  • National speciality committee chair and Program Director for Canada’s first official Clinician Educator Area of Focused Competency Diploma program under the Royal College of Physicians and Surgeons of Canada and Director of the program at McMaster
Dr. Lauren (Warren) Foster, PhD

Dr. Lauren (Warren) Foster, PhD

McMaster University, Department of Obstetrics & Gynecology
  • Patented method for diagnosis and monitoring of endometriosis, currently licensed and under development by an international women’s health pharmaceutical company
  • Expert in reproductive toxicology and the role of environmental toxicants on reproductive and endocrine health
Dr. Alison Fox-Robichaud, MD

Dr. Alison Fox-Robichaud, MD

McMaster University, Department of Medicine
  • Implemented electronic early warning scores into the medical records for Hamilton Health Sciences, and patented risk assessment tools for patients with sepsis
  • Studies translation of research in the pathophysiology of sepsis into clinical practices
Dr. Gail Gauvreau, PhD

Dr. Gail Gauvreau, PhD

McMaster University, Department of Medicine
  • Co-Director, AllerGen Clinical Investigator Collaborative (a clinical trial collaborative that investigates new drug candidates for respiratory diseases)
  • Co-author, Clinical Investigative Collaborative Operating Procedures (CIC-SOP) (has been licensed out to numerous times to pharmaceutical companies)
  • Interests in allergic inflammation and respiratory physiology, drug development, and clinical trial research
Dr. Peter Gross, MD

Dr. Peter Gross, MD

McMaster University, Department of Medicine
  • Founder, Twelve Squared Diagnostics (focused on development and commercialization of more efficient diagnostic techniques)
  • Prevention, diagnosis, and treatment of blood clotting disorders including venous thrombosis and haemophilia
Dr. Todd Hoare, PhD

Dr. Todd Hoare, PhD

McMaster University, Department of Chemical Engineering
  • Holds patents for a number of different devices for drug delivery and collaborates with numerous industry partners on product development and validation
  • Designs smart materials and gel nanoparticles for a vast range of biomedical applications including drug delivery methods
  • Successfully licensed university-based innovations to companies
Dr. Zeinab Hosseini-Doust, PhD

Dr. Zeinab Hosseini-Doust, PhD

McMaster University, Department of Chemical Engineering
  • Invented and filed a patent application on a regenerative bacteria-fighting gel, which has a variety of potential applications currently under development
  • Principle Investigator, Biohybrids Lab at McMaster University (integrates biology and synthetic nanoparticles to develop health solutions)
Dr. Peter Kavsak, PhD

Dr. Peter Kavsak, PhD

McMaster University, Department of Pathology & Molecular Medicine
  • Inventor on 3 patent families related to biomarker panel and methods; Adverse cardiac event risk score patent licensed and under development by global healthcare company with a focus on personalized diagnostics
  • Developed lab scores to identify patients at risk of heart attack as well as assessing risk of acute kidney injuries
Dr. Yingfu Li, PhD

Dr. Yingfu Li, PhD

McMaster University, Department of Biochemistry & Biomedical Sciences
  • Founder, InnovoGENE Biosciences Inc. (a research platform company providing aptamer-and DNAzyme-based services and assets; inventor on large portfolio of aptamer related patents)
  • Functional Nucleic Acids Research to make DNA-based enzymes and receptors (aptamers)
Dr. Brian Lichty, PhD

Dr. Brian Lichty, PhD

McMaster University, Department of Pathology & Molecular Medicine
  • Co-founder, Turnstone Biologics (an immune-oncology company) currently partnered with US company AbbVie Inc. to commercialize and market their oncolytic viral immunotherapies
  • Inventor on several oncolytic virus and method patents
  • Developing virus-based cancer immunotherapies
Dr. Andrew McArthur, PhD

Dr. Andrew McArthur, PhD

McMaster University, Department of Biochemistry & Biomedical Sciences, David Braley Centre for Antibiotic Discovery & M.G DeGroote Institute for Infectious Disease Research
  • Inventor of the Comprehensive Antibiotic Resistance Database and RGI software tools, the gold standard database for antimicrobial resistance surveillance and research (licensed by over 20 commercial partners)
  • Program Director, Biomedical Discovery and Commercialization
Dr. Karen Mossman, PhD

Dr. Karen Mossman, PhD

McMaster University, Department of Pathology & Molecular Medicine
  • Engineers herpesviruses to grow and kill cancer cells without harming healthy host cells
  • Inventor on provisional patents related to a novel oncolytic virus currently under development as a cancer therapeutic
Dr. William (Bill) Orovan, MD

Dr. William (Bill) Orovan, MD

McMaster University, Department of Surgery, Division of Urology
  • Medical Director,Maple Leaf HIFU (High Intensity Focused Ultrasound), Ablatherm® HIFU is a treatment of prostate cancer
  • Vice Dean, Clinical Services and Commercial Enterprises
Dr. Guillaume Paré, MD

Dr. Guillaume Paré, MD

McMaster University, Department of Pathology & Molecular Medicine
  • Scientific Advisor to numerous biotechnology companies, both large and small
  • Patented methods for the assessment of biochemical and genetic markers of disease risk
  • Researching the role of genetics in determining individuals at risk for cardiovascular diseases
Dr. Rolf Sebaldt, MDCM

Dr. Rolf Sebaldt, MDCM

McMaster University, Department of Medicine, Division of Rheumatology, Division of Clinical Pharmacology & Toxicology
  • President and CEO, Fig.P Software Incorporated (software design company that creates data management solutions for clinicians and researchers)
  • Director, ClinformaData Systems & Project Management
  • Interest in designing and implementing novel and scalable information technology-based solutions to improve clinical data capture and sustainable care quality improvement at point of care
Dr. Heather Sheardown, PhD

Dr. Heather Sheardown, PhD

McMaster University, Department of Chemical Engineering
  • Co-founder and Scientific Advisor, 20/20 Optimeyes (developers of drug delivery platform of ocular disease)
  • Working to develop new drug-containing formulations that act as topical eye drops, also innovations in drug delivery, contact lens materials, IOLs, polymer chemistry and bioengineering in the ophthalmic space
Dr. Leyla Soleymani, PhD

Dr. Leyla Soleymani, PhD

McMaster University, Department of Engineering Physics
  • Inventor on multiple patents for the development of electrodes and biosensing devices on the nano- and micro-scale
  • Co-Inventor on a diagnostic tool for endometriosis currently licensed and under development by an international women’s health pharmaceutical company
  • Research into material development for rapid prototyping techniques for faster implementation of novel healthcare diagnostics and monitoring platforms
Dr. Gregory Steinberg, PhD

Dr. Gregory Steinberg, PhD

McMaster University, Department of Medicine, Centre for Metabolism, Obesity and Diabetes Research
  • Co-founder and CSO, Espervita Therapeutics
  • Research focuses on developing new therapies for obesity, type 2 diabetes, NAFLD/NASH and liver cancer
  • Inventor on patents related to serotonin and growth differentiating factor 15 in metabolism
Dr. Richard Sztramko, MD

Dr. Richard Sztramko, MD

McMaster University, Department of Medicine, Division of Geriatrics
  • Chief Medical Officer, Reliq Health Technologies (remote patient monitoring, chronic disease management, and telemedicine solutions for Health Plans, Medicare, and Medicaid)
  • Co-founder, Arya Health Technologies (a next generation electronic health record and handover product)
  • Co-founder, iGericare (a comprehensive eLearning education platform for caregivers of people with dementia)
Dr. Mark Tarnopolsky, MD, PhD

Dr. Mark Tarnopolsky, MD, PhD

McMaster University, Department of Medicine, Division of Pediatrics
  • Founder, CEO, & CSO, Exerkine Corporation (a biotechnology company that commercializes exosome-based therapies for treatment of genetic diseases)
  • CSO, SofTab (a biotechnology company focusing on novel emulsion-based drug and nutrient delivery systems)
  • Former CSO, Life Science Nutritionals (LSN) (a nutraceutical company focusing on gummie based delivery systems)
  • Leader in assessment of pharmacologic, nutritional, and exercise interventions as treatments for patients with Neurometabolic disorders
Dr. Yonghong Wan, MD

Dr. Yonghong Wan, MD

McMaster University, Department of Pathology & Molecular Medicine
  • Inventor of family of patents related to oncolytic viruses and methods of use, licensed to Turnstone Biologics
  • Leader in combination therapy for cancer treatment using adoptive T cell therapy and oncolytic virus-based vaccines
  • Co-founder and CSO, Joint Therapeutics
Dr. Gerry Wright, PhD

Dr. Gerry Wright, PhD

McMaster University, Department of Biochemistry & Biomedical Sciences
  • Inventor on several patents related to novel antibiotics and drug discovery methods, as well as the CARD database currently licensed to over 20 industry partners
  • Director, Michael G. DeGroote Institute for Infectious Disease Research
  • The Wright Lab studies molecular mechanisms of bacterial antibiotic resistance while developing new antibiotics and novel antimicrobial strategies

Join Our Initiative

 

If you would like to keep informed about our events and opportunities, please sign up for our mailing list and follow us on social media.